7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Which patients with heart failure should receive specialist palliative care?

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          We investigated which patients with heart failure (HF) should receive specialist palliative care (SPC) by first creating a definition of need for SPC in patients hospitalised with HF using patient‐reported outcome measures (PROMs) and then testing this definition using the outcome of days alive and out of hospital (DAOH). We also evaluated which baseline variables predicted need for SPC and whether those with this need received SPC.

          Methods and results

          PROMs assessing quality of life (QoL), symptoms, and mood were administered at baseline and every 4 months. SPC need was defined as persistently severe impairment of any PROM without improvement (or severe impairment immediately preceding death). We then tested whether need for SPC, so defined, was reflected in DAOH, a measure which combines length of stay, days of hospital re‐admission, and days lost due to death. Of 272 patients recruited, 74 (27%) met the definition of SPC needs. These patients lived one third fewer DAOH than those without SPC need (and less than a quarter of QoL‐adjusted DAOH). A Kansas City Cardiomyopathy Questionnaire (KCCQ) summary score of <29 identified patients who subsequently had SPC needs (area under receiver operating characteristic curve 0.78). Twenty‐four per cent of patients with SPC needs actually received SPC ( n = 18).

          Conclusions

          A quarter of patients hospitalised with HF had a need for SPC and were identified by a low KCCQ score on admission. Those with SPC need spent many fewer DAOH and their DAOH were of significantly worse quality. Very few patients with SPC needs accessed SPC services.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          Index for rating diagnostic tests.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

              Heart failure with preserved ejection fraction (EF) is a common syndrome, but trends in treatments and outcomes are lacking. We analyzed data from 275 hospitals in Get With the Guidelines-Heart Failure from January 2005 to October 2010. Patients were stratified by EF as reduced EF (EF <40% [HF-reduced EF]), borderline EF (40%≤EF<50% [HF-borderline EF]), or preserved (EF ≥50% [HF-preserved EF]). Using multivariable models, we examined trends in therapies and outcomes. Among 110 621 patients, 50% (55 083) had HF-reduced EF, 14% (15 184) had HF-borderline EF, and 36% (40 354) had HF-preserved EF. From 2005 to 2010, the proportion of hospitalizations for HF-preserved EF increased from 33% to 39% (P<0.0001). In multivariable analyses, use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers at discharge decreased in all EF groups, and β-blocker use increased. Patients with HF-preserved EF less frequently achieved blood pressure control (adjusted odds ratio, 0.44 versus HF-reduced EF; P<0.001) and were more likely discharged to skilled nursing (adjusted odds ratio, 1.16 versus HF-reduced EF; P<0.001). In-hospital mortality for HF-preserved EF decreased from 3.32% in 2005 to 2.35% in 2010 (adjusted odds ratio, 0.89 per year; P=0.01) but was stable for patients with HF-reduced EF (3.03%-2.83%; adjusted odds ratio, 0.93 per year; P=0.10). Hospitalization for HF-preserved EF is increasing relative to HF-reduced EF. Although in-hospital mortality for patients with HF-preserved EF declined over the study period, an important opportunity remains for identifying evidence-based therapies in patients with HF-preserved EF.
                Bookmark

                Author and article information

                Contributors
                john.mcmurray@glasgow.ac.uk
                Journal
                Eur J Heart Fail
                Eur. J. Heart Fail
                10.1002/(ISSN)1879-0844
                EJHF
                European Journal of Heart Failure
                John Wiley & Sons, Ltd (Oxford, UK )
                1388-9842
                1879-0844
                28 June 2018
                September 2018
                28 June 2018
                : 20
                : 9 ( doiID: 10.1002/ejhf.2018.20.issue-9 )
                : 1338-1347
                Affiliations
                [ 1 ] BHF Cardiovascular Research Centre University of Glasgow Glasgow UK
                [ 2 ] SNAHFS Golden Jubilee National Hospital Scotland UK
                [ 3 ] Queen Elizabeth University Hospital Scotland UK
                [ 4 ] Hospital Papa Giovanni XXIII Bergamo Italy
                [ 5 ] Robertson Centre for Biostatistics University of Glasgow Glasgow UK
                [ 6 ] Johns Hopkins University Baltimore MD USA
                [ 7 ] Edinburgh University Edinburgh UK
                [ 8 ] Hull York Medical School University of Hull Hull UK
                [ 9 ] Glasgow Royal Infirmary Glasgow UK
                Author notes
                [*] [* ]Corresponding author. Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK. Tel: +44 141 330 3479, Fax: +44 141 330 6955, Email: john.mcmurray@ 123456glasgow.ac.uk
                Article
                EJHF1240
                10.1002/ejhf.1240
                6607479
                29952090
                1eeb57af-986c-475f-9622-5092c9beadde
                © 2018 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 24 January 2018
                : 16 April 2018
                : 21 May 2018
                Page count
                Figures: 4, Tables: 4, Pages: 10, Words: 5966
                Funding
                Funded by: British Heart Foundation
                Award ID: PG/13/17/30050
                Categories
                Research Article
                Treatment
                Research Article
                Custom metadata
                2.0
                ejhf1240
                September 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.0 mode:remove_FC converted:08.10.2018

                Cardiovascular Medicine
                heart failure,palliative care
                Cardiovascular Medicine
                heart failure, palliative care

                Comments

                Comment on this article